Global Analytics & Insights Director - Oncology & IO

AstraZeneca; Gaithersburg (MD); Hybrid; USD 195,000 - 293,000; Full time

Job summary

AstraZeneca is seeking a Global Analytics & Insights Director – Oncology to join the GA&I team and support the Oncology organization with a focus on Immuno-Oncology. You will lead insights that shape strategy, synthesize analyses into clear recommendations, and influence senior stakeholders in a fast-growing biopharma environment.

This role requires leading cross-functional initiatives, building therapy-area expertise, and translating research into actionable guidance that informs forecasts,

Qualifications

• Advanced degree in science or mathematics.
• Pharma industry experience in-house, consulting, or investment/finance.
• Qualitative and quantitative market research experience.
• Understanding of commercial brand strategy and oncology exposure.

Responsibilities

• Frame key business questions in ambiguous situations and define the most appropriate analytical approach.
• Provide strategy-shaping analysis from diverse sources and integrate insights to advise material business decisions.
• Lead market research identifying actions to address brand business problems with tumor-level knowledge beyond the brand.
• Interpret primary market research with business acumen to generate evidence-based, actionable insights.
• Develop competitive intelligence and align forecasts with brand thinking across functions.

Skills

Advanced degree

Oncology experience

Market research (qual/quant)

Commercial brand strategy

Pharma industry experience

Education

Advanced degree in science/mathematics

Job description

AstraZeneca is seeking a Global Analytics & Insights Director – Oncology to join the GA&I team and support the Oncology organization with a focus on Immuno-Oncology. You will lead insights that shape strategy, synthesize analyses into clear recommendations, and influence senior stakeholders in a fast-growing biopharma environment.

This role requires leading cross-functional initiatives, building therapy-area expertise, and translating research into actionable guidance that informs forecasts,